SlideShare a Scribd company logo
Total slides – 93
Presenter
Dr Rachit Sharma
Junior Resident (Psychiatry)
Armed Forces Medical College,
Pune
Moderator
Dr VS Chauhan
Assoc Prof (Psychiatry)
Armed Forces Medical College,
Pune
2
Benefit exceeds Risk :Case Vignette
3
Torous J, Roberts LW. The ethical use of mobile health technology in clinical psychiatry. The Journal of nervous
and mental disease. 2017 Jan 1;205(1):4-8.
Benefit exceeds Risk :Case Vignette
4
Torous J, Roberts LW. The ethical use of mobile health technology in clinical psychiatry. The Journal of nervous
and mental disease. 2017 Jan 1;205(1):4-8.
Risk exceeds benefit: Case Vignette
5
Torous J, Roberts LW. The ethical use of mobile health technology in clinical psychiatry. The Journal of nervous
and mental disease. 2017 Jan 1;205(1):4-8.
Risk exceeds benefit: Case Vignette
6
Torous J, Roberts LW. The ethical use of mobile health technology in clinical psychiatry. The Journal of nervous
and mental disease. 2017 Jan 1;205(1):4-8.
Why I chose this article?
• Rapid development in the app industry – Multiple
apps are being developed daily
• Recent focus- a shift to Mental health apps
• 2nd National CME on Media and Mental Health –
Delegates were educated about these apps
 Used in what all disorders?
 How effective are these apps ?
 Used Adjunct or alone ?
 How long their effect lasts?
7
Why I chose this article?
• Searched – Google scholar, PubMed,
ResearchGate
• MeSH words – mHealth, mental health apps,
e-Health apps, smartphone apps AND
Psychiatric illness, anxiety, depression, stress
AND systemic reviews, meta-analysis
8
Overview
INTRODUCTION
• Background
• Related studies
ARTICLE
• Aim and Objectives
• Material and Methods
• Statistical Methods
• Results
• Discussion
• Strengths & Limitations
• Critique
• Legal issues in e-Health
9
Background
10
Background
• 1,60,000 health-related apps available in the
Google Play and Apple app (2015)
• Nearly 1/3 of disease specific apps have a
mental health focus
• Over half of mobile phone users had
downloaded a health-related app
• Support for a variety of mental illnesses -
Depression, Anxiety, Schizophrenia, Addiction
and Eating disorders
11
Benefits
• Reduce barriers to mental health services
1. Cost, distance, wait-times, and stigma
surrounding receiving treatment
2. Improve the mental health support such as real-
time monitoring
3. Promote user autonomy by facilitating an
increase in self-awareness and self-efficacy skills
12
Robillard JM, Feng TL, Sporn AB, Lai JA, Lo C, Ta M, Nadler R. Availability, readability, and content of privacy
policies and terms of agreements of mental health apps. Internet Interventions. 2019 Sep 1;17:100243.
Risks
1. Apps may be vulnerable to technical issues that may
disrupt the availability of the services
2. Quality of the services - Whether apps underwent
any any formal technical testing ?
3. Harm potential - Whether information provided is
accurate and evidence-based?
4. Discouragement in seeking professional help -
Believing that the app alone can suffice
5. Potential security and privacy risks
13
Robillard JM, Feng TL, Sporn AB, Lai JA, Lo C, Ta M, Nadler R. Availability, readability, and content of privacy
policies and terms of agreements of mental health apps. Internet Interventions. 2019 Sep 1;17:100243.
Background
14
Menon V, Rajan TM, Sarkar S. Psychotherapeutic applications of mobile phone-based technologies: A systematic review of current research and
trends. Indian J Psychol Med 2017;39:4-11.
mHealth apps
15
Related studies
16
Related Study 1
17
-
Related Study 1: Abstract
18
Related Study 1: Results
19
Related Study 2
20
Related Study 2: Abstract
21
Related Study 2: Results
22
Related Study 2: Results
23
Related Study 2: Results
24
Article in focus
25
Article in focus
World Psychiatry
• Impact Factor 34.024 (2018)
• Rank 02/ 453 (SJR)
• Triannual
• Editor-Prof Mario Mej
Department of Psychiatry
University of Naples, Naples
Italy
27
http://www.scimagojr.com/journalrank.php?category=2738&area=2700&year=2019
Lead Author
28
• Dr Jake Linardon, Ph.D
School of Psychology, Deakin University,
Victoria, Australia
Publications – 38
• Areas of interest –
• Eating disorders, Body image
Aim
1. To evaluate the efficacy of app-supported
smart phone interventions on a range of
mental health outcomes
2. To examine whether various features related
to the intervention (theoretical orientation,
professional guidance, reminders to engage) and sample
(degree of mental health problem) moderated the
observed effect sizes
29
Material and Methods
• Nature of Study
– Meta analysis of randomized control trials
30
Material and Methods
• Intervention
– App based Smart phone intervention to improve
mental health or general well-being.
– Trials of interventions delivered only in part via
smartphone
• Adjunctive designs (smartphone app + standard
therapy vs. standard therapy alone)
• Blended intervention programs (when participants
could access the app-based intervention via
smartphones or computers)
31
Material and Methods
Control condition
• Waitlist
• Assessment only
• Treatment as usual
• Informational and
educational resources
• Attention/placebo
controls
Active Intervention
• Standard face-to-face
therapy
• Web-based or
computerized
interventions
• Pharmacotherapy
• Self-monitoring
conditions
32
Comparison conditions
Material and Methods
• Main outcome
– Effect of smart phone apps on Depressive,
Generalized Anxiety, Stress levels and Quality of
life (Using self reported proforma)
• Additional outcome
– Effect of smart phone apps on specific anxiety
symptoms (social anxiety symptoms, panic
symptoms, post-traumatic stress symptoms)
General distress, Positive and Negative affect
33
Inclusion Criteria
• RCTs (Published and unpublished) with following
criteria
– Language - English
– Studies that examined the effects of an app-
supported smartphone intervention
– Comparison with a control condition or an active
intervention
– Interventions involving adjunctive designs and
blended intervention programs
34
Exclusion Criteria
• RCT with following criteria-
– Using interventions that were not based on
mental health or well being
– Using interventions that uses computerized
intervention, a virtual reality exposure treatment,
or a text messaging only
– No relevant comparison condition, no outcome
measure was reported
– If the authors failed to provide the data for effect
size calculation
35
Progression of study
36
• Literature Search - December 2018
– Medline, PsycINFO, Cochrane databases, Web of
Science)
– Reference lists of included studies and previous
reviews were also hand-searched to identify
any further eligible studies
– Trial registries - ClinicalTrials.gov and
clinicaltrialsregister.eu.
Progression of study
• MeSH words - “smartphone*” OR “mobile phone”
OR “cell phone” OR “mobile app*” OR “iphone” OR “android”
OR “mhealth” OR “m-health” OR “cellular phone” OR “mobile
device*” OR “mobile-based” OR "mobile health" OR “tablet-
based”) AND (“random*” OR “trial*” OR “allocat*”) AND
(“anxiety” OR “agoraphobia” OR “phobia*” OR “panic” OR
“post-traumatic stress” OR “mental health” OR “mental
illness*” OR “depress*” OR “affective disorder*” OR “bipolar”
OR “mood disorder*” OR “psychosis” OR “psychotic” OR
“schizophre*” OR “well-being” OR “wellbeing” OR “quality of
life” OR “self-harm” or “self-injury” OR “stress*” OR
“distress*” OR “mood” OR “body image” OR “eating
disorder*”
37
Progression of study
• Data extraction
– Authors independently screened the titles and
abstracts yielded by the search against the
inclusion criteria
– Articles were downloaded and again screened in
detail for the inclusion criteria
– If needed Additional information from study
authors was sought (data for calculation of effect
size)
38
Progression of study
• Risk of bias assessment
– Cochrane Collaboration bias assessment tool
– 4 criteria were used
– Low risk - When outcome data used to calculate
effect size were based on ITT analyses
– Unpublished studies by checking pre-registration
of trials
39
PRISMA: Flow Chart
40
PRISMA: Flow Chart
41
Statistical Analysis
1. Comprehensive Meta-Analysis Version 3.0
2. Random effects model with use of standard
mean difference
3. Effect size - Hedge’s ‘g’
4. For Heterogeneity – I2
5. Significance - Q value
6. Publication Bias –
1. Trim-and-fil procedure
2. Begg and Mazumdar rank correlation test
42
Tests of significance : Q value
• P-value gives you the probability of a false
positive on a single test.
• Q-value is a P-value that has been adjusted for
the False Discovery Rate (FDR)
• FDR - Proportion of false positives expected
out of a test
• Use of Q-values - If you’re running hundreds
or thousands of tests from small samples
(common in fields like genomics)
43
Tests of significance : Q value
44
• P-values tell you the percentage of
false positives to expect and take
into account the number of tests
being run
• Q-value doesn’t take into account all the tests; they
only take into account the tests that are below a
threshold that you choose (i.e. tests reporting a q-
value of 5% or less)
Results
45
Results
• 66 RCTs
– 38 RCT
• Depression (14), Anxiety (9), Stress (8)
– 28 RCT
• General well-being
• 77 smartphone intervention conditions
• 73 Apps
– Cognitive and/or behavioral principles (35)
– Acceptance- or mindfulness-based principles (38)
• 46
Results
• Some RCTs – App v/s Active
intervention/Control
• Some RCTs – App v/s Control/Blended/
Adjunctive
47
Results
Effect on depressive symptoms
• Smartphone interventions vs. Controls
• Smartphone interventions vs. active
comparisons
• Additive effects of smartphone interventions
to standard intervention
48
Results
Effect on depressive symptoms
49
Results
Effect on depressive symptoms
50
Results
Effect on depressive symptoms
51
Effect on depressive symptoms
52
Effect on depressive symptoms
53
Results
Effect on Gen. Anxiety symptoms
• Smartphone interventions vs. Controls
• Subgroup analysis
• Smartphone interventions vs. Active
comparisons
54
Results
Effect on Gen. Anxiety symptoms
55
Results
Effect on Gen. Anxiety symptoms
56
Results
Effect on Gen. Anxiety symptoms
57
Effect on Gen. Anxiety symptoms
58
Effect on Gen. Anxiety symptoms
59
Results
• Efficacy of smartphone interventions on stress
levels
• Efficacy of smartphone interventions on well
being/quality of life
60
Results
Effect on Stress levels
61
Results
Effect on Stress levels
62
Results
Effect on Stress levels
• *********
63
Results
Effect on Quality of life
64
Results
Effect on Quality of life
65
Results
Effect on Quality of life
66
Results
• Efficacy of smartphone interventions on other
outcomes
67
Effect on other outcomes
68
Bias Assessment
Bias criteria fulfilled
(More the criteria
less is the bias)
No of studies
(Out of 66)
% of studies
4/4 17 25.7 %
3/4 16 24.2%
2/4 27 40.9%
1/4 6 9.1%
69
Discussion
70
Discussion
1. Mental health apps - g= 0.28 to 0.58 with
respect to control conditions in improving
various symptoms (depressive symptoms, anxiety
symptoms, stress levels, general psychological distress,
quality of life, and positive affect)
2. Statistically significant effect sizes were
observed in both symptomatic and non-
symptomatic population
71
Discussion
3. Apps with professional guidance and
engagement reminders - bolstered the
effectiveness of smartphone interventions
4. CBT based interventions produced larger
effects for anxiety and stress
5. Smartphone interventions did not
significantly differ from active interventions
on any outcome
72
Limitations (as per author)
1. Possible negative effects of smartphone
interventions were not assessed
2. Long-term sustainability of effects of
smartphone interventions were not assessed
3. Outcomes were assessed via selfreport
questionnaires - Effect size estimates may be
slightly underestimated
73
My comments
• Strengths
1. The study has given comprehensive review of
mental health apps for symptomatic as well as
normal population
2. It has added an update to existing data, which
was very pertinent as far as rapidly developing
m-Health is concerned
74
My comments
• Limitations
1. No comment on no. of participants,
Intervention and Control distribution
2. No comment on data on severity of symptoms
on inclusion, types of self reported
questionnaire
3. Population characteristics and Intervention
context not explained
4. Didn’t address the bias adequately
75
Sample
76
Take home message
• Apps can serve as a easily accessible
intervention for people who has psychological
symptoms of low intensity
• Apps with inbuilt support for professional
guidance or personalized feedback from
therapists or research staff produced larger
effect sizes
77
Checklist
Criteria Yes
(2)
Partial
(1)
No
(0)
N/A
1 Question/ objective sufficiently
described?
√
2 Study design evident &
appropriate?
√
3 Inclusion & Exclusion Criteria
characteristics sufficiently
described?
√
4 Sample size appropriate? √
5 Results reported in sufficient
detail?
√
78
Checklist
Criteria Yes
(2)
Partial
(1)
No
(0)
N/A
6 Analytic methods
described/justified &
appropriate?
√
7 Conclusions supported by the
results?
√
8 Controlled for confounding? √
9 Outcome measures well-
defined and robust to
measurement/misclassification
bias? Means of assessment
reported
√
79
Critique
• Clear message: 3/5
• Contribution to literature: 3/5
• Potential to change thinking or practice: 2/5
• Quality of manuscript: 2/5
Legal issues in e-Health
81
Legal issues in e-Health
• Examples of e-Health
– Telemedicine
– Robot assisted surgery
– Self-monitoring health care devices
– Electronic health records
– Health service aggregation (e.g. JUST DIAL,
SULEKHA, 1 mg)
– m-Health
– e-Pharmacy (1 mg, NetMeds)
82
Where are we?
83
Malpractice and Liability
• Duty of care and medical liability
– Laxman Balkrishna Joshi (Dr.) v/s Dr. Trimbak Bapu
Godbole (1968)
• Duty of care in deciding whether to undertake the case
• Duty of care in deciding what treatment to give
• Duty of care in the administration of that treatment
– Indian Medical Association v/s V.P. Shantha (1995)
• Applicability of Consumer Protection Act, 1986 to
persons engaged in the medical profession either as
private practitioners or as government doctors
84
Laws applicable to telemedicine
1. Drugs and Cosmetics Act, 1940, and Drugs and Cosmetics Rules,
1945
2. Indian Medical Council Act, 1956
3. Indian Medical Council (Professional conduct, Etiquette and Ethics)
Regulations, 2002
4. Clinical Establishments (Registration and Regulation) Act, 2010 (‘Clinical
Establishments Act’)
5. Information Technology Act, 2000 (IT Act)
6. Information Technology (Reasonable Security Practices and Procedures
and Sensitive Personal Data or Information) Rules, 2011
7. Information Technology (Intermediaries Guidelines) Rules, 2011
8. Unsolicited Commercial Communications Regulations, 2007
9. Telecom Commercial Communication Customer Preference Regulations,
2010 (‘TCCP Regulations’)
85
Ajay Garg. Legal issues in telemedicine. Diplomatic Square 2019 May 19. Available from
https://www.diplomaticsquare.com/ legal-issues-in-telemedicine/ Assessed on 13 Oct 2019
Laws applicable to telemedicine
• Section 4 & 5 of IT Act 2000 - Legal recognition to the
electronic record and digital signatures. Amended
Indian Evidence Act, 1872 thereby making the
electronic record admissible in evidence
• Section 2(1)(t) of the IT Act 2000 defines “electronic
record” as data, record or data generated, image or
sound stored, received or sent in an electronic form
or micro film or computer generated micro fiche.
86
Ajay Garg. Legal issues in telemedicine. Diplomatic Square 2019 May 19. Available from
https://www.diplomaticsquare.com/ legal-issues-in-telemedicine/ Assessed on 13 Oct 2019
Right of patient
• A conference between the telemedicine physician
and the treating physician has been considered to be
a direct interaction in order to determine the
existence of a doctor-patient relationship (Wheeler v.
Yettie Kersting Memorial Hospital)
• Even minimal contacts between doctors and patients
via telemedicine may establish a sufficient
relationship for malpractice liability
87
Ajay Garg. Legal issues in telemedicine. Diplomatic Square 2019 May 19. Available from
https://www.diplomaticsquare.com/ legal-issues-in-telemedicine/ Assessed on 13 Oct 2019
Right of patient
• No relationship will normally be considered to have
arisen-where the doctor-patient interaction arose
because of an emergency situation where the doctor
was forced to treat the patient (Paschim Banga Khet Mazdoor
Samity v. State of West Bengal)
88
Ajay Garg. Legal issues in telemedicine. Diplomatic Square 2019 May 19. Available from
https://www.diplomaticsquare.com/ legal-issues-in-telemedicine/ Assessed on 13 Oct 2019
Informed Consent
• Patient’s consent- Patient must be informed about
the nature of the telemedical application, its risks
and any alternative means of transferring their data.
The consent must be in writing and laid down in an
appropriate document
• Must inform the patient of the potential risks,
consequences and benefits of telemedicine
89
Ateriya N, Saraf A, Meshram VP, Setia P. Telemedicine and virtual consultation: The Indian perspective. The
National medical journal of India. 2018 Jul 1;31(4):215.
Privacy
• Privacy and Doctor-Patient relationship –
– A doctor cannot disclose to a person any information
regarding his patient which he has gathered in the course
of treatment nor can the doctor disclose to anyone else
the mode of treatment or the advice given by him to the
patient
– Information regarding a person’s physical condition,
psychological condition, healthcare and treatment shall
not be released without the patient’s consent
90
Ateriya N, Saraf A, Meshram VP, Setia P. Telemedicine and virtual consultation: The Indian perspective. The
National medical journal of India. 2018 Jul 1;31(4):215.
Grey areas
• Regarding e-Health - The standards of care for the
same have not been determined so far
• Also, medical malpractice case has not yet been
brought against a Cyber Physician (CP)
• It can be argued that because the doctor has not
seen the patient, that the doctor’s duty is not as
strong
• In regard to the same argument, contributory
negligence by the patient could be established
91
Grey areas
• If a CP fails to respond to request for medical
attention and the patient suffers injury, it is possible
that a doctor-patient relationship would be deemed
to exist and the physician would be held liable
• If the CP is on vacation and the indl believing to
receive a timely response suffers an injury because of
the cyberdoctor’s failure to respond – No clarity
regarding the responsibility
92
Ateriya N, Saraf A, Meshram VP, Setia P. Telemedicine and virtual consultation: The Indian perspective. The
National medical journal of India. 2018 Jul 1;31(4):215.
93
Thank You

More Related Content

Similar to The efficacy of app-supported smartphone interventions for mental health problems: a meta-analysis of randomized controlled trials

User requirements for smartphone apps
User requirements for smartphone apps User requirements for smartphone apps
User requirements for smartphone apps
NIHR_MindTech
 
# 4th lect HSR
# 4th lect  HSR# 4th lect  HSR
# 4th lect HSR
Dr. Eman M. Mortada
 
Health Need Assessment
Health Need AssessmentHealth Need Assessment
Health Need Assessment
Rajbir Kaur
 
Facilitating cross-talk in mHealth intervention development
Facilitating cross-talk in mHealth intervention developmentFacilitating cross-talk in mHealth intervention development
Facilitating cross-talk in mHealth intervention development
Megan Ranney
 
Georgetown Innovation Center for Biomedical Informatics Symposium Precision ...
 Georgetown Innovation Center for Biomedical Informatics Symposium Precision ... Georgetown Innovation Center for Biomedical Informatics Symposium Precision ...
Georgetown Innovation Center for Biomedical Informatics Symposium Precision ...
Warren Kibbe
 
Evaluation methods in heathcare systems
Evaluation methods in heathcare systemsEvaluation methods in heathcare systems
Evaluation methods in heathcare systems
Marsa Gholamzadeh
 
Healthcare analytics
Healthcare analytics Healthcare analytics
Healthcare analytics
Arun K
 
How to address privacy, ethical and regulatory issues: Examples in cognitive ...
How to address privacy, ethical and regulatory issues: Examples in cognitive ...How to address privacy, ethical and regulatory issues: Examples in cognitive ...
How to address privacy, ethical and regulatory issues: Examples in cognitive ...
SharpBrains
 
Precision and Participatory Medicine - MEDINFO 2015 Panel on big data
Precision and Participatory Medicine - MEDINFO 2015 Panel on big dataPrecision and Participatory Medicine - MEDINFO 2015 Panel on big data
Precision and Participatory Medicine - MEDINFO 2015 Panel on big data
Health and Biomedical Informatics Centre @ The University of Melbourne
 
Mie2015 workshop-adherence engaging-publicized
Mie2015 workshop-adherence engaging-publicizedMie2015 workshop-adherence engaging-publicized
Mie2015 workshop-adherence engaging-publicized
Pei-Yun Sabrina Hsueh
 
Dr V K Tiwari
Dr V K TiwariDr V K Tiwari
Dr V K Tiwari
IAPSMUPUKCON2010
 
The EQ-5D and Its Use Internationally
The EQ-5D and Its Use InternationallyThe EQ-5D and Its Use Internationally
The EQ-5D and Its Use Internationally
Office of Health Economics
 
Presentation (2).pptx
Presentation (2).pptxPresentation (2).pptx
Presentation (2).pptx
Jaibhagwan47
 
Score iSYS Health Apps
Score iSYS Health AppsScore iSYS Health Apps
Score iSYS Health Apps
Funancion iSYS
 
IPS poster 2014
IPS poster 2014IPS poster 2014
IPS poster 2014
Steven Chan, MD MBA
 
First approach of mobile applications study for medical Education purposes
First approach of mobile applications study for medical Education purposesFirst approach of mobile applications study for medical Education purposes
First approach of mobile applications study for medical Education purposes
Technological Ecosystems for Enhancing Multiculturality
 
Critical appraisal of published medical research (2)
Critical appraisal of published medical research (2)Critical appraisal of published medical research (2)
Critical appraisal of published medical research (2)
Tarek Tawfik Amin
 
AI applications in life sciences - drug development
AI applications in life sciences - drug developmentAI applications in life sciences - drug development
AI applications in life sciences - drug development
Jayanthi Repalli, PhD
 
Mobile Apps in Clinical Settings
Mobile Apps in Clinical SettingsMobile Apps in Clinical Settings
Mobile Apps in Clinical Settings
National Center for Telehealth & Technology
 
Theory and Practice of Integrating Machine Learning and Conventional Statisti...
Theory and Practice of Integrating Machine Learning and Conventional Statisti...Theory and Practice of Integrating Machine Learning and Conventional Statisti...
Theory and Practice of Integrating Machine Learning and Conventional Statisti...
University of Malaya
 

Similar to The efficacy of app-supported smartphone interventions for mental health problems: a meta-analysis of randomized controlled trials (20)

User requirements for smartphone apps
User requirements for smartphone apps User requirements for smartphone apps
User requirements for smartphone apps
 
# 4th lect HSR
# 4th lect  HSR# 4th lect  HSR
# 4th lect HSR
 
Health Need Assessment
Health Need AssessmentHealth Need Assessment
Health Need Assessment
 
Facilitating cross-talk in mHealth intervention development
Facilitating cross-talk in mHealth intervention developmentFacilitating cross-talk in mHealth intervention development
Facilitating cross-talk in mHealth intervention development
 
Georgetown Innovation Center for Biomedical Informatics Symposium Precision ...
 Georgetown Innovation Center for Biomedical Informatics Symposium Precision ... Georgetown Innovation Center for Biomedical Informatics Symposium Precision ...
Georgetown Innovation Center for Biomedical Informatics Symposium Precision ...
 
Evaluation methods in heathcare systems
Evaluation methods in heathcare systemsEvaluation methods in heathcare systems
Evaluation methods in heathcare systems
 
Healthcare analytics
Healthcare analytics Healthcare analytics
Healthcare analytics
 
How to address privacy, ethical and regulatory issues: Examples in cognitive ...
How to address privacy, ethical and regulatory issues: Examples in cognitive ...How to address privacy, ethical and regulatory issues: Examples in cognitive ...
How to address privacy, ethical and regulatory issues: Examples in cognitive ...
 
Precision and Participatory Medicine - MEDINFO 2015 Panel on big data
Precision and Participatory Medicine - MEDINFO 2015 Panel on big dataPrecision and Participatory Medicine - MEDINFO 2015 Panel on big data
Precision and Participatory Medicine - MEDINFO 2015 Panel on big data
 
Mie2015 workshop-adherence engaging-publicized
Mie2015 workshop-adherence engaging-publicizedMie2015 workshop-adherence engaging-publicized
Mie2015 workshop-adherence engaging-publicized
 
Dr V K Tiwari
Dr V K TiwariDr V K Tiwari
Dr V K Tiwari
 
The EQ-5D and Its Use Internationally
The EQ-5D and Its Use InternationallyThe EQ-5D and Its Use Internationally
The EQ-5D and Its Use Internationally
 
Presentation (2).pptx
Presentation (2).pptxPresentation (2).pptx
Presentation (2).pptx
 
Score iSYS Health Apps
Score iSYS Health AppsScore iSYS Health Apps
Score iSYS Health Apps
 
IPS poster 2014
IPS poster 2014IPS poster 2014
IPS poster 2014
 
First approach of mobile applications study for medical Education purposes
First approach of mobile applications study for medical Education purposesFirst approach of mobile applications study for medical Education purposes
First approach of mobile applications study for medical Education purposes
 
Critical appraisal of published medical research (2)
Critical appraisal of published medical research (2)Critical appraisal of published medical research (2)
Critical appraisal of published medical research (2)
 
AI applications in life sciences - drug development
AI applications in life sciences - drug developmentAI applications in life sciences - drug development
AI applications in life sciences - drug development
 
Mobile Apps in Clinical Settings
Mobile Apps in Clinical SettingsMobile Apps in Clinical Settings
Mobile Apps in Clinical Settings
 
Theory and Practice of Integrating Machine Learning and Conventional Statisti...
Theory and Practice of Integrating Machine Learning and Conventional Statisti...Theory and Practice of Integrating Machine Learning and Conventional Statisti...
Theory and Practice of Integrating Machine Learning and Conventional Statisti...
 

More from RachitSharma132

AUTISM SPECTRUM DISORDER, CHILDHOOD AUTISM, ATYPICAL AUTISM
AUTISM SPECTRUM DISORDER, CHILDHOOD AUTISM, ATYPICAL AUTISMAUTISM SPECTRUM DISORDER, CHILDHOOD AUTISM, ATYPICAL AUTISM
AUTISM SPECTRUM DISORDER, CHILDHOOD AUTISM, ATYPICAL AUTISM
RachitSharma132
 
Approach to adolescent turmoil
Approach to adolescent turmoilApproach to adolescent turmoil
Approach to adolescent turmoil
RachitSharma132
 
SEMINAR - THE NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES ACT
SEMINAR - THE NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES ACTSEMINAR - THE NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES ACT
SEMINAR - THE NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES ACT
RachitSharma132
 
Gender Identity Disorder/ Gender Dysphoria
Gender Identity Disorder/ Gender DysphoriaGender Identity Disorder/ Gender Dysphoria
Gender Identity Disorder/ Gender Dysphoria
RachitSharma132
 
Journal Club presentation- Neurotrophins, cytokines, oxidative stress mediato...
Journal Club presentation- Neurotrophins, cytokines, oxidative stress mediato...Journal Club presentation- Neurotrophins, cytokines, oxidative stress mediato...
Journal Club presentation- Neurotrophins, cytokines, oxidative stress mediato...
RachitSharma132
 
JOURNAL CLUB - Association of Lithium in Drinking Water With the Incidence of...
JOURNAL CLUB - Association of Lithium in Drinking Water With the Incidence of...JOURNAL CLUB - Association of Lithium in Drinking Water With the Incidence of...
JOURNAL CLUB - Association of Lithium in Drinking Water With the Incidence of...
RachitSharma132
 
Journal Club presentation- Mood stabilizers and risk of stroke in bipolar dis...
Journal Club presentation- Mood stabilizers and risk of stroke in bipolar dis...Journal Club presentation- Mood stabilizers and risk of stroke in bipolar dis...
Journal Club presentation- Mood stabilizers and risk of stroke in bipolar dis...
RachitSharma132
 

More from RachitSharma132 (7)

AUTISM SPECTRUM DISORDER, CHILDHOOD AUTISM, ATYPICAL AUTISM
AUTISM SPECTRUM DISORDER, CHILDHOOD AUTISM, ATYPICAL AUTISMAUTISM SPECTRUM DISORDER, CHILDHOOD AUTISM, ATYPICAL AUTISM
AUTISM SPECTRUM DISORDER, CHILDHOOD AUTISM, ATYPICAL AUTISM
 
Approach to adolescent turmoil
Approach to adolescent turmoilApproach to adolescent turmoil
Approach to adolescent turmoil
 
SEMINAR - THE NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES ACT
SEMINAR - THE NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES ACTSEMINAR - THE NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES ACT
SEMINAR - THE NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES ACT
 
Gender Identity Disorder/ Gender Dysphoria
Gender Identity Disorder/ Gender DysphoriaGender Identity Disorder/ Gender Dysphoria
Gender Identity Disorder/ Gender Dysphoria
 
Journal Club presentation- Neurotrophins, cytokines, oxidative stress mediato...
Journal Club presentation- Neurotrophins, cytokines, oxidative stress mediato...Journal Club presentation- Neurotrophins, cytokines, oxidative stress mediato...
Journal Club presentation- Neurotrophins, cytokines, oxidative stress mediato...
 
JOURNAL CLUB - Association of Lithium in Drinking Water With the Incidence of...
JOURNAL CLUB - Association of Lithium in Drinking Water With the Incidence of...JOURNAL CLUB - Association of Lithium in Drinking Water With the Incidence of...
JOURNAL CLUB - Association of Lithium in Drinking Water With the Incidence of...
 
Journal Club presentation- Mood stabilizers and risk of stroke in bipolar dis...
Journal Club presentation- Mood stabilizers and risk of stroke in bipolar dis...Journal Club presentation- Mood stabilizers and risk of stroke in bipolar dis...
Journal Club presentation- Mood stabilizers and risk of stroke in bipolar dis...
 

Recently uploaded

Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
drhasanrajab
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Donc Test
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 

Recently uploaded (20)

Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 

The efficacy of app-supported smartphone interventions for mental health problems: a meta-analysis of randomized controlled trials

  • 1. Total slides – 93 Presenter Dr Rachit Sharma Junior Resident (Psychiatry) Armed Forces Medical College, Pune Moderator Dr VS Chauhan Assoc Prof (Psychiatry) Armed Forces Medical College, Pune
  • 2. 2
  • 3. Benefit exceeds Risk :Case Vignette 3 Torous J, Roberts LW. The ethical use of mobile health technology in clinical psychiatry. The Journal of nervous and mental disease. 2017 Jan 1;205(1):4-8.
  • 4. Benefit exceeds Risk :Case Vignette 4 Torous J, Roberts LW. The ethical use of mobile health technology in clinical psychiatry. The Journal of nervous and mental disease. 2017 Jan 1;205(1):4-8.
  • 5. Risk exceeds benefit: Case Vignette 5 Torous J, Roberts LW. The ethical use of mobile health technology in clinical psychiatry. The Journal of nervous and mental disease. 2017 Jan 1;205(1):4-8.
  • 6. Risk exceeds benefit: Case Vignette 6 Torous J, Roberts LW. The ethical use of mobile health technology in clinical psychiatry. The Journal of nervous and mental disease. 2017 Jan 1;205(1):4-8.
  • 7. Why I chose this article? • Rapid development in the app industry – Multiple apps are being developed daily • Recent focus- a shift to Mental health apps • 2nd National CME on Media and Mental Health – Delegates were educated about these apps  Used in what all disorders?  How effective are these apps ?  Used Adjunct or alone ?  How long their effect lasts? 7
  • 8. Why I chose this article? • Searched – Google scholar, PubMed, ResearchGate • MeSH words – mHealth, mental health apps, e-Health apps, smartphone apps AND Psychiatric illness, anxiety, depression, stress AND systemic reviews, meta-analysis 8
  • 9. Overview INTRODUCTION • Background • Related studies ARTICLE • Aim and Objectives • Material and Methods • Statistical Methods • Results • Discussion • Strengths & Limitations • Critique • Legal issues in e-Health 9
  • 11. Background • 1,60,000 health-related apps available in the Google Play and Apple app (2015) • Nearly 1/3 of disease specific apps have a mental health focus • Over half of mobile phone users had downloaded a health-related app • Support for a variety of mental illnesses - Depression, Anxiety, Schizophrenia, Addiction and Eating disorders 11
  • 12. Benefits • Reduce barriers to mental health services 1. Cost, distance, wait-times, and stigma surrounding receiving treatment 2. Improve the mental health support such as real- time monitoring 3. Promote user autonomy by facilitating an increase in self-awareness and self-efficacy skills 12 Robillard JM, Feng TL, Sporn AB, Lai JA, Lo C, Ta M, Nadler R. Availability, readability, and content of privacy policies and terms of agreements of mental health apps. Internet Interventions. 2019 Sep 1;17:100243.
  • 13. Risks 1. Apps may be vulnerable to technical issues that may disrupt the availability of the services 2. Quality of the services - Whether apps underwent any any formal technical testing ? 3. Harm potential - Whether information provided is accurate and evidence-based? 4. Discouragement in seeking professional help - Believing that the app alone can suffice 5. Potential security and privacy risks 13 Robillard JM, Feng TL, Sporn AB, Lai JA, Lo C, Ta M, Nadler R. Availability, readability, and content of privacy policies and terms of agreements of mental health apps. Internet Interventions. 2019 Sep 1;17:100243.
  • 14. Background 14 Menon V, Rajan TM, Sarkar S. Psychotherapeutic applications of mobile phone-based technologies: A systematic review of current research and trends. Indian J Psychol Med 2017;39:4-11.
  • 18. Related Study 1: Abstract 18
  • 19. Related Study 1: Results 19
  • 21. Related Study 2: Abstract 21
  • 22. Related Study 2: Results 22
  • 23. Related Study 2: Results 23
  • 24. Related Study 2: Results 24
  • 27. World Psychiatry • Impact Factor 34.024 (2018) • Rank 02/ 453 (SJR) • Triannual • Editor-Prof Mario Mej Department of Psychiatry University of Naples, Naples Italy 27 http://www.scimagojr.com/journalrank.php?category=2738&area=2700&year=2019
  • 28. Lead Author 28 • Dr Jake Linardon, Ph.D School of Psychology, Deakin University, Victoria, Australia Publications – 38 • Areas of interest – • Eating disorders, Body image
  • 29. Aim 1. To evaluate the efficacy of app-supported smart phone interventions on a range of mental health outcomes 2. To examine whether various features related to the intervention (theoretical orientation, professional guidance, reminders to engage) and sample (degree of mental health problem) moderated the observed effect sizes 29
  • 30. Material and Methods • Nature of Study – Meta analysis of randomized control trials 30
  • 31. Material and Methods • Intervention – App based Smart phone intervention to improve mental health or general well-being. – Trials of interventions delivered only in part via smartphone • Adjunctive designs (smartphone app + standard therapy vs. standard therapy alone) • Blended intervention programs (when participants could access the app-based intervention via smartphones or computers) 31
  • 32. Material and Methods Control condition • Waitlist • Assessment only • Treatment as usual • Informational and educational resources • Attention/placebo controls Active Intervention • Standard face-to-face therapy • Web-based or computerized interventions • Pharmacotherapy • Self-monitoring conditions 32 Comparison conditions
  • 33. Material and Methods • Main outcome – Effect of smart phone apps on Depressive, Generalized Anxiety, Stress levels and Quality of life (Using self reported proforma) • Additional outcome – Effect of smart phone apps on specific anxiety symptoms (social anxiety symptoms, panic symptoms, post-traumatic stress symptoms) General distress, Positive and Negative affect 33
  • 34. Inclusion Criteria • RCTs (Published and unpublished) with following criteria – Language - English – Studies that examined the effects of an app- supported smartphone intervention – Comparison with a control condition or an active intervention – Interventions involving adjunctive designs and blended intervention programs 34
  • 35. Exclusion Criteria • RCT with following criteria- – Using interventions that were not based on mental health or well being – Using interventions that uses computerized intervention, a virtual reality exposure treatment, or a text messaging only – No relevant comparison condition, no outcome measure was reported – If the authors failed to provide the data for effect size calculation 35
  • 36. Progression of study 36 • Literature Search - December 2018 – Medline, PsycINFO, Cochrane databases, Web of Science) – Reference lists of included studies and previous reviews were also hand-searched to identify any further eligible studies – Trial registries - ClinicalTrials.gov and clinicaltrialsregister.eu.
  • 37. Progression of study • MeSH words - “smartphone*” OR “mobile phone” OR “cell phone” OR “mobile app*” OR “iphone” OR “android” OR “mhealth” OR “m-health” OR “cellular phone” OR “mobile device*” OR “mobile-based” OR "mobile health" OR “tablet- based”) AND (“random*” OR “trial*” OR “allocat*”) AND (“anxiety” OR “agoraphobia” OR “phobia*” OR “panic” OR “post-traumatic stress” OR “mental health” OR “mental illness*” OR “depress*” OR “affective disorder*” OR “bipolar” OR “mood disorder*” OR “psychosis” OR “psychotic” OR “schizophre*” OR “well-being” OR “wellbeing” OR “quality of life” OR “self-harm” or “self-injury” OR “stress*” OR “distress*” OR “mood” OR “body image” OR “eating disorder*” 37
  • 38. Progression of study • Data extraction – Authors independently screened the titles and abstracts yielded by the search against the inclusion criteria – Articles were downloaded and again screened in detail for the inclusion criteria – If needed Additional information from study authors was sought (data for calculation of effect size) 38
  • 39. Progression of study • Risk of bias assessment – Cochrane Collaboration bias assessment tool – 4 criteria were used – Low risk - When outcome data used to calculate effect size were based on ITT analyses – Unpublished studies by checking pre-registration of trials 39
  • 42. Statistical Analysis 1. Comprehensive Meta-Analysis Version 3.0 2. Random effects model with use of standard mean difference 3. Effect size - Hedge’s ‘g’ 4. For Heterogeneity – I2 5. Significance - Q value 6. Publication Bias – 1. Trim-and-fil procedure 2. Begg and Mazumdar rank correlation test 42
  • 43. Tests of significance : Q value • P-value gives you the probability of a false positive on a single test. • Q-value is a P-value that has been adjusted for the False Discovery Rate (FDR) • FDR - Proportion of false positives expected out of a test • Use of Q-values - If you’re running hundreds or thousands of tests from small samples (common in fields like genomics) 43
  • 44. Tests of significance : Q value 44 • P-values tell you the percentage of false positives to expect and take into account the number of tests being run • Q-value doesn’t take into account all the tests; they only take into account the tests that are below a threshold that you choose (i.e. tests reporting a q- value of 5% or less)
  • 46. Results • 66 RCTs – 38 RCT • Depression (14), Anxiety (9), Stress (8) – 28 RCT • General well-being • 77 smartphone intervention conditions • 73 Apps – Cognitive and/or behavioral principles (35) – Acceptance- or mindfulness-based principles (38) • 46
  • 47. Results • Some RCTs – App v/s Active intervention/Control • Some RCTs – App v/s Control/Blended/ Adjunctive 47
  • 48. Results Effect on depressive symptoms • Smartphone interventions vs. Controls • Smartphone interventions vs. active comparisons • Additive effects of smartphone interventions to standard intervention 48
  • 52. Effect on depressive symptoms 52
  • 53. Effect on depressive symptoms 53
  • 54. Results Effect on Gen. Anxiety symptoms • Smartphone interventions vs. Controls • Subgroup analysis • Smartphone interventions vs. Active comparisons 54
  • 55. Results Effect on Gen. Anxiety symptoms 55
  • 56. Results Effect on Gen. Anxiety symptoms 56
  • 57. Results Effect on Gen. Anxiety symptoms 57
  • 58. Effect on Gen. Anxiety symptoms 58
  • 59. Effect on Gen. Anxiety symptoms 59
  • 60. Results • Efficacy of smartphone interventions on stress levels • Efficacy of smartphone interventions on well being/quality of life 60
  • 63. Results Effect on Stress levels • ********* 63
  • 67. Results • Efficacy of smartphone interventions on other outcomes 67
  • 68. Effect on other outcomes 68
  • 69. Bias Assessment Bias criteria fulfilled (More the criteria less is the bias) No of studies (Out of 66) % of studies 4/4 17 25.7 % 3/4 16 24.2% 2/4 27 40.9% 1/4 6 9.1% 69
  • 71. Discussion 1. Mental health apps - g= 0.28 to 0.58 with respect to control conditions in improving various symptoms (depressive symptoms, anxiety symptoms, stress levels, general psychological distress, quality of life, and positive affect) 2. Statistically significant effect sizes were observed in both symptomatic and non- symptomatic population 71
  • 72. Discussion 3. Apps with professional guidance and engagement reminders - bolstered the effectiveness of smartphone interventions 4. CBT based interventions produced larger effects for anxiety and stress 5. Smartphone interventions did not significantly differ from active interventions on any outcome 72
  • 73. Limitations (as per author) 1. Possible negative effects of smartphone interventions were not assessed 2. Long-term sustainability of effects of smartphone interventions were not assessed 3. Outcomes were assessed via selfreport questionnaires - Effect size estimates may be slightly underestimated 73
  • 74. My comments • Strengths 1. The study has given comprehensive review of mental health apps for symptomatic as well as normal population 2. It has added an update to existing data, which was very pertinent as far as rapidly developing m-Health is concerned 74
  • 75. My comments • Limitations 1. No comment on no. of participants, Intervention and Control distribution 2. No comment on data on severity of symptoms on inclusion, types of self reported questionnaire 3. Population characteristics and Intervention context not explained 4. Didn’t address the bias adequately 75
  • 77. Take home message • Apps can serve as a easily accessible intervention for people who has psychological symptoms of low intensity • Apps with inbuilt support for professional guidance or personalized feedback from therapists or research staff produced larger effect sizes 77
  • 78. Checklist Criteria Yes (2) Partial (1) No (0) N/A 1 Question/ objective sufficiently described? √ 2 Study design evident & appropriate? √ 3 Inclusion & Exclusion Criteria characteristics sufficiently described? √ 4 Sample size appropriate? √ 5 Results reported in sufficient detail? √ 78
  • 79. Checklist Criteria Yes (2) Partial (1) No (0) N/A 6 Analytic methods described/justified & appropriate? √ 7 Conclusions supported by the results? √ 8 Controlled for confounding? √ 9 Outcome measures well- defined and robust to measurement/misclassification bias? Means of assessment reported √ 79
  • 80. Critique • Clear message: 3/5 • Contribution to literature: 3/5 • Potential to change thinking or practice: 2/5 • Quality of manuscript: 2/5
  • 81. Legal issues in e-Health 81
  • 82. Legal issues in e-Health • Examples of e-Health – Telemedicine – Robot assisted surgery – Self-monitoring health care devices – Electronic health records – Health service aggregation (e.g. JUST DIAL, SULEKHA, 1 mg) – m-Health – e-Pharmacy (1 mg, NetMeds) 82
  • 84. Malpractice and Liability • Duty of care and medical liability – Laxman Balkrishna Joshi (Dr.) v/s Dr. Trimbak Bapu Godbole (1968) • Duty of care in deciding whether to undertake the case • Duty of care in deciding what treatment to give • Duty of care in the administration of that treatment – Indian Medical Association v/s V.P. Shantha (1995) • Applicability of Consumer Protection Act, 1986 to persons engaged in the medical profession either as private practitioners or as government doctors 84
  • 85. Laws applicable to telemedicine 1. Drugs and Cosmetics Act, 1940, and Drugs and Cosmetics Rules, 1945 2. Indian Medical Council Act, 1956 3. Indian Medical Council (Professional conduct, Etiquette and Ethics) Regulations, 2002 4. Clinical Establishments (Registration and Regulation) Act, 2010 (‘Clinical Establishments Act’) 5. Information Technology Act, 2000 (IT Act) 6. Information Technology (Reasonable Security Practices and Procedures and Sensitive Personal Data or Information) Rules, 2011 7. Information Technology (Intermediaries Guidelines) Rules, 2011 8. Unsolicited Commercial Communications Regulations, 2007 9. Telecom Commercial Communication Customer Preference Regulations, 2010 (‘TCCP Regulations’) 85 Ajay Garg. Legal issues in telemedicine. Diplomatic Square 2019 May 19. Available from https://www.diplomaticsquare.com/ legal-issues-in-telemedicine/ Assessed on 13 Oct 2019
  • 86. Laws applicable to telemedicine • Section 4 & 5 of IT Act 2000 - Legal recognition to the electronic record and digital signatures. Amended Indian Evidence Act, 1872 thereby making the electronic record admissible in evidence • Section 2(1)(t) of the IT Act 2000 defines “electronic record” as data, record or data generated, image or sound stored, received or sent in an electronic form or micro film or computer generated micro fiche. 86 Ajay Garg. Legal issues in telemedicine. Diplomatic Square 2019 May 19. Available from https://www.diplomaticsquare.com/ legal-issues-in-telemedicine/ Assessed on 13 Oct 2019
  • 87. Right of patient • A conference between the telemedicine physician and the treating physician has been considered to be a direct interaction in order to determine the existence of a doctor-patient relationship (Wheeler v. Yettie Kersting Memorial Hospital) • Even minimal contacts between doctors and patients via telemedicine may establish a sufficient relationship for malpractice liability 87 Ajay Garg. Legal issues in telemedicine. Diplomatic Square 2019 May 19. Available from https://www.diplomaticsquare.com/ legal-issues-in-telemedicine/ Assessed on 13 Oct 2019
  • 88. Right of patient • No relationship will normally be considered to have arisen-where the doctor-patient interaction arose because of an emergency situation where the doctor was forced to treat the patient (Paschim Banga Khet Mazdoor Samity v. State of West Bengal) 88 Ajay Garg. Legal issues in telemedicine. Diplomatic Square 2019 May 19. Available from https://www.diplomaticsquare.com/ legal-issues-in-telemedicine/ Assessed on 13 Oct 2019
  • 89. Informed Consent • Patient’s consent- Patient must be informed about the nature of the telemedical application, its risks and any alternative means of transferring their data. The consent must be in writing and laid down in an appropriate document • Must inform the patient of the potential risks, consequences and benefits of telemedicine 89 Ateriya N, Saraf A, Meshram VP, Setia P. Telemedicine and virtual consultation: The Indian perspective. The National medical journal of India. 2018 Jul 1;31(4):215.
  • 90. Privacy • Privacy and Doctor-Patient relationship – – A doctor cannot disclose to a person any information regarding his patient which he has gathered in the course of treatment nor can the doctor disclose to anyone else the mode of treatment or the advice given by him to the patient – Information regarding a person’s physical condition, psychological condition, healthcare and treatment shall not be released without the patient’s consent 90 Ateriya N, Saraf A, Meshram VP, Setia P. Telemedicine and virtual consultation: The Indian perspective. The National medical journal of India. 2018 Jul 1;31(4):215.
  • 91. Grey areas • Regarding e-Health - The standards of care for the same have not been determined so far • Also, medical malpractice case has not yet been brought against a Cyber Physician (CP) • It can be argued that because the doctor has not seen the patient, that the doctor’s duty is not as strong • In regard to the same argument, contributory negligence by the patient could be established 91
  • 92. Grey areas • If a CP fails to respond to request for medical attention and the patient suffers injury, it is possible that a doctor-patient relationship would be deemed to exist and the physician would be held liable • If the CP is on vacation and the indl believing to receive a timely response suffers an injury because of the cyberdoctor’s failure to respond – No clarity regarding the responsibility 92 Ateriya N, Saraf A, Meshram VP, Setia P. Telemedicine and virtual consultation: The Indian perspective. The National medical journal of India. 2018 Jul 1;31(4):215.

Editor's Notes

  1. Good afternoon everyone. Today I ll be presenting a journal article which is published in World Psychiatry October edition.
  2. Our watch, alarms, Calender, engagements, communication( happy, sad, angry, turmoil), social media, Payments, Bank transactions, travel, Entertainment – and now physical and Mental health
  3. India is 3rd largest phone market in the world. 60,000 health-related apps available in the Google Play and Apple app stores collectively (Xu and Liu, 2015) and over half of mobile phone users had downloaded a health-related app, highlighting the popularity of using smartphones as a health tool (Krebs and Duncan, 2015). Within the group of health-related apps, a major subcategory is apps aimed at supporting users' mental health: nearly one-third of diseasespecifi apps have a mental health focus (Anthes, 2016)
  4. such as cost, distance, wait-times, and the stigma surrounding receiving treatment or support for mental health issues help to promote user autonomy by facilitating an increase in self-awareness and self-efficacy skills
  5. ACHESS – Alcohol Comprehensive Health Enhancement Support System
  6. (theoretical orientation, whether professional guidance was offered, whether reminders to engage were sent) and sample (degree of mental health problem) moderated the observed effct sizes
  7. No restrictions on the samples were applied
  8. waitlist, assessment only, treatment as usual, informational and educational resources (e.g., website links, health tips), or attention/placebo controls (e.g., gaming apps, music-listening conditions) Active interventions were categorized as standard face-to-face therapy, web-based or computerized interventions, pharmacotherapy, and self-monitoring conditions
  9. No comment on blinding Control conditions were categorized as waitlist, assessment only, treatment as usual, informational and educational resources (e.g., website links, health tips), or attention/placebo controls (e.g., gaming apps, music-listening conditions). Active interventions were categorized as standard face-to-face therapy, web-based or computerized interventions, pharmacotherapy, and self-monitoring conditions Adjunctive designs (smartphone app + standard therapy vs. standard therapy alone) Blended intervention programs (when participants could access the app-based intervention via smartphones or computers)
  10. We excluded reviews, pilot/single dose studies, case reports, and case series no relevant comparison condition (e.g., a two-arm trial comparing two apps was excluded) or no outcome measure was reported. If a study did not include data for effct size calculation, the authors were contacted, and the study was excluded if they failed to provide the data. If a study did not include data for effect size calculation, the authors were contacted, and the study was excluded if they failed to provide the data.
  11. Not searched - EMBASE, PsyARTICLES, ScienceDirect
  12. Random sequence generation Allocation concealment Blinding of participants and personnel Blinding of outcome assessment Incomplete outcome data Selective reporting Other bias - Funding
  13. Imagine you’re planning scratch off lottery, and you have a 5% chance of getting a winning ticket. One ticket gives you a 5% chance, but if you buy enough tickets, probability tells us that you’ll eventually get a winner (buying 1,000 lottery tickets should do the trick and will in fact give you, on average, 50 winning tickets). The same is true for lab tests. The first test on your data, you have a 5% chance of a false positive. The second test on your data, you have another 5% chance of a false positive. The thousandth test on your data, you have had a 5% chance of a false positive a thousand times.
  14. Bonferroni correction - reduce the number of false positives but they also reduce the number of true discoveries The False Discovery Rate approach is a more recent development It controls the number of false discoveries in those tests that result in a discovery (i.e. a significant result)
  15. Regular day care, psychoeducation about illness, social skills training, morning stretching exercises
  16. these effects were robust even after performing various sensitivity analyses that adjusted for common biasing factors in RCTs, including the type of control condition, trial risk of bias rating, and publication bias further highlighting the potential that smartphone apps could bring within current models of mental health care –low cost, easily assessible, user friendly option for universal, selective or indicative preventive program- fit within the stepped-care model
  17. 3. the involvement of a therapist can be costly and may thus restrict the capacity of smartphone apps to reach the millions of people around the world in need of (and who cannot gain access to) treatment 4. too few head-to-head comparisons of diffrent smartphone interventions have been performed, and those that compared CBT vs. non-CBT-based smartphone interventions reported no differences in level of symptom improvement 5. few studies contributed to these head-to-head comparisons, so these analyses may have been underpowered
  18. Since they were not reported in the included studies Due to large differences in follow-up times and since drop-outs were dealt with inconsistently across studies. it is unclear whether improvements in mental health are sustained after the period of the study A previous meta-analysis demonstrated that clinician-rated instruments yield signifiantly larger effect sizes in psychotherapy trials than self-reported measures
  19. Last study was done in 2017
  20. 3.Not our practice but definitely of clientelle. It has equipped us with hard facts to educate our clientelle about the mental health apps and their role
  21. Telemedicine is a blend of information and communication technologies (ICTs) with medical science
  22. The transfer and exchange of medical information in telemedicinal applications must always be legitimated by the patient’s consent. This means that the
  23. The technical committee of Department of Information Technology in India in its report has also recommended that the Information regarding a person’s physical condition, psychological condition, healthcare and treatment shall not be released without the patient’s consent.
  24. No clarity regarding the responsibility to respond in regard to treatment or to notify the patient that he or she cannot assist them for any reason